- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-4-mer
- Ligands
- 20 x CA: CALCIUM ION(Non-covalent)
CA.1: 5 residues within 4Å:- Chain A: D.22, D.24, D.26, T.28, E.33
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.22, A:D.26, A:T.28, A:E.33, A:E.33
CA.2: 6 residues within 4Å:- Chain A: D.58, D.60, N.62, T.64, D.66, E.69
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.58, A:D.60, A:T.64, A:E.69, A:E.69
CA.3: 5 residues within 4Å:- Chain A: D.95, D.97, N.99, Y.101, E.106
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.95, A:D.97, A:Y.101, A:E.106, A:E.106
CA.4: 6 residues within 4Å:- Chain A: D.131, D.133, D.135, Q.137, N.139, E.142
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.131, A:D.135, A:Q.137, A:E.142, A:E.142
CA.5: 5 residues within 4Å:- Chain C: D.22, D.24, D.26, T.28, E.33
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.22, C:D.26, C:T.28, C:E.33, C:E.33
CA.6: 6 residues within 4Å:- Chain C: D.58, D.60, N.62, T.64, D.66, E.69
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.58, C:D.60, C:T.64, C:E.69, C:E.69
CA.7: 5 residues within 4Å:- Chain C: D.95, D.97, N.99, Y.101, E.106
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.95, C:D.97, C:Y.101, C:E.106, C:E.106
CA.8: 6 residues within 4Å:- Chain C: D.131, D.133, D.135, Q.137, N.139, E.142
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.131, C:D.135, C:Q.137, C:E.142, C:E.142
CA.9: 5 residues within 4Å:- Chain D: D.22, D.24, D.26, T.28, E.33
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:D.22, D:D.26, D:T.28, D:E.33, D:E.33
CA.10: 6 residues within 4Å:- Chain D: D.58, D.60, N.62, T.64, D.66, E.69
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:D.58, D:D.60, D:T.64, D:E.69, D:E.69
CA.11: 5 residues within 4Å:- Chain D: D.95, D.97, N.99, Y.101, E.106
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:D.95, D:D.97, D:Y.101, D:E.106, D:E.106
CA.12: 6 residues within 4Å:- Chain D: D.131, D.133, D.135, Q.137, N.139, E.142
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:D.131, D:D.135, D:Q.137, D:E.142, D:E.142
CA.13: 5 residues within 4Å:- Chain E: D.22, D.24, D.26, T.28, E.33
5 PLIP interactions:5 interactions with chain E- Metal complexes: E:D.22, E:D.26, E:T.28, E:E.33, E:E.33
CA.14: 6 residues within 4Å:- Chain E: D.58, D.60, N.62, T.64, D.66, E.69
5 PLIP interactions:5 interactions with chain E- Metal complexes: E:D.58, E:D.60, E:T.64, E:E.69, E:E.69
CA.15: 5 residues within 4Å:- Chain E: D.95, D.97, N.99, Y.101, E.106
5 PLIP interactions:5 interactions with chain E- Metal complexes: E:D.95, E:D.97, E:Y.101, E:E.106, E:E.106
CA.16: 6 residues within 4Å:- Chain E: D.131, D.133, D.135, Q.137, N.139, E.142
5 PLIP interactions:5 interactions with chain E- Metal complexes: E:D.131, E:D.135, E:Q.137, E:E.142, E:E.142
CA.18: 3 residues within 4Å:- Chain F: E.3893, E.3967, T.5001
4 PLIP interactions:4 interactions with chain F- Metal complexes: F:E.3893, F:E.3967, F:E.3967, F:T.5001
CA.26: 3 residues within 4Å:- Chain J: E.3893, E.3967, T.5001
4 PLIP interactions:4 interactions with chain J- Metal complexes: J:E.3893, J:E.3967, J:E.3967, J:T.5001
CA.34: 3 residues within 4Å:- Chain K: E.3893, E.3967, T.5001
4 PLIP interactions:4 interactions with chain K- Metal complexes: K:E.3893, K:E.3967, K:E.3967, K:T.5001
CA.42: 3 residues within 4Å:- Chain L: E.3893, E.3967, T.5001
4 PLIP interactions:4 interactions with chain L- Metal complexes: L:E.3893, L:E.3967, L:E.3967, L:T.5001
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.17: 14 residues within 4Å:- Chain F: K.4211, K.4214, R.4215, M.4954, E.4955, K.4957, C.4958, F.4959, I.4960, F.4975, T.4979, H.4983, N.4984, L.4985
11 PLIP interactions:11 interactions with chain F- Hydrogen bonds: F:F.4959, F:I.4960, F:T.4979, F:H.4983, F:L.4985
- Salt bridges: F:K.4211, F:K.4211, F:K.4214, F:K.4214, F:K.4214, F:R.4215
ATP.21: 11 residues within 4Å:- Chain F: R.886, R.897, D.899, N.921, M.924, H.993, W.996, R.1000, R.1020, N.1035
- Ligands: KVR.22
9 PLIP interactions:9 interactions with chain F- Hydrogen bonds: F:R.886, F:N.921, F:H.993, F:R.1000, F:N.1018, F:N.1035
- Salt bridges: F:R.897, F:R.1020
- pi-Stacking: F:W.996
ATP.25: 14 residues within 4Å:- Chain J: K.4211, K.4214, R.4215, M.4954, E.4955, K.4957, C.4958, F.4959, I.4960, F.4975, T.4979, H.4983, N.4984, L.4985
11 PLIP interactions:11 interactions with chain J- Hydrogen bonds: J:F.4959, J:I.4960, J:T.4979, J:H.4983, J:L.4985
- Salt bridges: J:K.4211, J:K.4211, J:K.4214, J:K.4214, J:K.4214, J:R.4215
ATP.29: 11 residues within 4Å:- Chain J: R.886, R.897, D.899, N.921, M.924, H.993, W.996, R.1000, R.1020, N.1035
- Ligands: KVR.30
9 PLIP interactions:9 interactions with chain J- Hydrogen bonds: J:R.886, J:N.921, J:H.993, J:R.1000, J:N.1018, J:N.1035
- Salt bridges: J:R.897, J:R.1020
- pi-Stacking: J:W.996
ATP.33: 14 residues within 4Å:- Chain K: K.4211, K.4214, R.4215, M.4954, E.4955, K.4957, C.4958, F.4959, I.4960, F.4975, T.4979, H.4983, N.4984, L.4985
11 PLIP interactions:11 interactions with chain K- Hydrogen bonds: K:F.4959, K:I.4960, K:T.4979, K:H.4983, K:L.4985
- Salt bridges: K:K.4211, K:K.4211, K:K.4214, K:K.4214, K:K.4214, K:R.4215
ATP.37: 11 residues within 4Å:- Chain K: R.886, R.897, D.899, N.921, M.924, H.993, W.996, R.1000, R.1020, N.1035
- Ligands: KVR.38
9 PLIP interactions:9 interactions with chain K- Hydrogen bonds: K:R.886, K:N.921, K:H.993, K:R.1000, K:N.1018, K:N.1035
- Salt bridges: K:R.897, K:R.1020
- pi-Stacking: K:W.996
ATP.41: 14 residues within 4Å:- Chain L: K.4211, K.4214, R.4215, M.4954, E.4955, K.4957, C.4958, F.4959, I.4960, F.4975, T.4979, H.4983, N.4984, L.4985
11 PLIP interactions:11 interactions with chain L- Hydrogen bonds: L:F.4959, L:I.4960, L:T.4979, L:H.4983, L:L.4985
- Salt bridges: L:K.4211, L:K.4211, L:K.4214, L:K.4214, L:K.4214, L:R.4215
ATP.45: 11 residues within 4Å:- Chain L: R.886, R.897, D.899, N.921, M.924, H.993, W.996, R.1000, R.1020, N.1035
- Ligands: KVR.46
9 PLIP interactions:9 interactions with chain L- Hydrogen bonds: L:R.886, L:N.921, L:H.993, L:R.1000, L:N.1018, L:N.1035
- Salt bridges: L:R.897, L:R.1020
- pi-Stacking: L:W.996
- 4 x ZN: ZINC ION(Non-covalent)
ZN.19: 4 residues within 4Å:- Chain F: C.4958, C.4961, H.4978, H.4983
4 PLIP interactions:4 interactions with chain F- Metal complexes: F:C.4958, F:C.4961, F:H.4978, F:H.4983
ZN.27: 4 residues within 4Å:- Chain J: C.4958, C.4961, H.4978, H.4983
4 PLIP interactions:4 interactions with chain J- Metal complexes: J:C.4958, J:C.4961, J:H.4978, J:H.4983
ZN.35: 4 residues within 4Å:- Chain K: C.4958, C.4961, H.4978, H.4983
4 PLIP interactions:4 interactions with chain K- Metal complexes: K:C.4958, K:C.4961, K:H.4978, K:H.4983
ZN.43: 4 residues within 4Å:- Chain L: C.4958, C.4961, H.4978, H.4983
4 PLIP interactions:4 interactions with chain L- Metal complexes: L:C.4958, L:C.4961, L:H.4978, L:H.4983
- 4 x CFF: CAFFEINE(Non-covalent)
CFF.20: 5 residues within 4Å:- Chain F: F.3753, E.4239, W.4716, I.4996, W.5011
3 PLIP interactions:3 interactions with chain F- pi-Stacking: F:W.4716, F:W.4716, F:W.4716
CFF.28: 5 residues within 4Å:- Chain J: F.3753, E.4239, W.4716, I.4996, W.5011
3 PLIP interactions:3 interactions with chain J- pi-Stacking: J:W.4716, J:W.4716, J:W.4716
CFF.36: 5 residues within 4Å:- Chain K: F.3753, E.4239, W.4716, I.4996, W.5011
3 PLIP interactions:3 interactions with chain K- pi-Stacking: K:W.4716, K:W.4716, K:W.4716
CFF.44: 5 residues within 4Å:- Chain L: F.3753, E.4239, W.4716, I.4996, W.5011
3 PLIP interactions:3 interactions with chain L- pi-Stacking: L:W.4716, L:W.4716, L:W.4716
- 4 x KVR: 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)methyl]benzoic acid(Non-covalent)
KVR.22: 10 residues within 4Å:- Chain F: H.879, W.882, H.904, C.906, L.913, E.917, R.918, Y.920, N.921
- Ligands: ATP.21
6 PLIP interactions:6 interactions with chain F- Hydrophobic interactions: F:W.882, F:Y.920
- Hydrogen bonds: F:E.917
- Salt bridges: F:H.879, F:H.904
- pi-Cation interactions: F:W.882
KVR.30: 10 residues within 4Å:- Chain J: H.879, W.882, H.904, C.906, L.913, E.917, R.918, Y.920, N.921
- Ligands: ATP.29
6 PLIP interactions:6 interactions with chain J- Hydrophobic interactions: J:W.882, J:Y.920
- Hydrogen bonds: J:E.917
- Salt bridges: J:H.879, J:H.904
- pi-Cation interactions: J:W.882
KVR.38: 10 residues within 4Å:- Chain K: H.879, W.882, H.904, C.906, L.913, E.917, R.918, Y.920, N.921
- Ligands: ATP.37
6 PLIP interactions:6 interactions with chain K- Hydrophobic interactions: K:W.882, K:Y.920
- Hydrogen bonds: K:E.917
- Salt bridges: K:H.879, K:H.904
- pi-Cation interactions: K:W.882
KVR.46: 10 residues within 4Å:- Chain L: H.879, W.882, H.904, C.906, L.913, E.917, R.918, Y.920, N.921
- Ligands: ATP.45
6 PLIP interactions:6 interactions with chain L- Hydrophobic interactions: L:W.882, L:Y.920
- Hydrogen bonds: L:E.917
- Salt bridges: L:H.879, L:H.904
- pi-Cation interactions: L:W.882
- 8 x L9R: (2S)-3-(octadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
L9R.23: 13 residues within 4Å:- Chain F: V.4847, L.4850, Y.4851, N.4857, F.4858, F.4859, Y.4909, Y.4912, F.4916, F.4923
- Chain K: Y.4630, N.4805
- Ligands: L9R.40
11 PLIP interactions:11 interactions with chain F- Hydrophobic interactions: F:V.4847, F:L.4850, F:Y.4851, F:Y.4851, F:F.4858, F:F.4858, F:F.4859, F:Y.4912, F:F.4916, F:F.4923
- Hydrogen bonds: F:Y.4909
L9R.24: 14 residues within 4Å:- Chain F: W.4794, V.4797, L.4801, Y.4804, N.4805, F.4807, F.4808, A.4811, L.4814
- Chain J: L.4850, V.4853, N.4857, F.4858
- Ligands: L9R.31
10 PLIP interactions:7 interactions with chain F, 3 interactions with chain J- Hydrophobic interactions: F:V.4797, F:L.4801, F:L.4801, F:F.4808, F:A.4811, F:L.4814, J:L.4850, J:V.4853, J:F.4858
- Hydrogen bonds: F:N.4805
L9R.31: 13 residues within 4Å:- Chain F: Y.4630, N.4805
- Chain J: V.4847, L.4850, Y.4851, N.4857, F.4858, F.4859, Y.4909, Y.4912, F.4916, F.4923
- Ligands: L9R.24
11 PLIP interactions:11 interactions with chain J- Hydrophobic interactions: J:V.4847, J:L.4850, J:Y.4851, J:Y.4851, J:F.4858, J:F.4858, J:F.4859, J:Y.4912, J:F.4916, J:F.4923
- Hydrogen bonds: J:Y.4909
L9R.32: 13 residues within 4Å:- Chain J: W.4794, V.4797, L.4801, Y.4804, N.4805, F.4807, F.4808, A.4811, L.4814
- Chain L: V.4853, N.4857, F.4858
- Ligands: L9R.47
9 PLIP interactions:7 interactions with chain J, 2 interactions with chain L- Hydrophobic interactions: J:V.4797, J:L.4801, J:L.4801, J:F.4808, J:A.4811, J:L.4814, L:V.4853, L:F.4858
- Hydrogen bonds: J:N.4805
L9R.39: 13 residues within 4Å:- Chain K: V.4847, L.4850, Y.4851, N.4857, F.4858, F.4859, Y.4909, Y.4912, F.4916, F.4923
- Chain L: Y.4630, N.4805
- Ligands: L9R.48
11 PLIP interactions:11 interactions with chain K- Hydrophobic interactions: K:V.4847, K:L.4850, K:Y.4851, K:Y.4851, K:F.4858, K:F.4858, K:F.4859, K:Y.4912, K:F.4916, K:F.4923
- Hydrogen bonds: K:Y.4909
L9R.40: 12 residues within 4Å:- Chain F: N.4857, F.4858
- Chain K: W.4794, V.4797, L.4801, Y.4804, N.4805, F.4807, F.4808, A.4811, L.4814
- Ligands: L9R.23
8 PLIP interactions:7 interactions with chain K, 1 interactions with chain F- Hydrophobic interactions: K:V.4797, K:L.4801, K:L.4801, K:F.4808, K:A.4811, K:L.4814, F:F.4858
- Hydrogen bonds: K:N.4805
L9R.47: 13 residues within 4Å:- Chain J: Y.4630, N.4805
- Chain L: V.4847, L.4850, Y.4851, N.4857, F.4858, F.4859, Y.4909, Y.4912, F.4916, F.4923
- Ligands: L9R.32
11 PLIP interactions:11 interactions with chain L- Hydrophobic interactions: L:V.4847, L:L.4850, L:Y.4851, L:Y.4851, L:F.4858, L:F.4858, L:F.4859, L:Y.4912, L:F.4916, L:F.4923
- Hydrogen bonds: L:Y.4909
L9R.48: 14 residues within 4Å:- Chain K: L.4850, V.4853, N.4857, F.4858
- Chain L: W.4794, V.4797, L.4801, Y.4804, N.4805, F.4807, F.4808, A.4811, L.4814
- Ligands: L9R.39
10 PLIP interactions:7 interactions with chain L, 3 interactions with chain K- Hydrophobic interactions: L:V.4797, L:L.4801, L:L.4801, L:F.4808, L:A.4811, L:L.4814, K:L.4850, K:V.4853, K:F.4858
- Hydrogen bonds: L:N.4805
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Miotto, M.C., Targeting Ryanodine Receptors with Allopurinol and Xanthine Derivatives for the Treatment of Cardiac and Musculoskeletal Weakness Disorders. To Be Published
- Release Date
- 2024-10-30
- Peptides
- Calmodulin-1: ACDE
Peptidyl-prolyl cis-trans isomerase FKBP1A: BGHI
Ryanodine receptor 1: FJKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
KC
DD
EE
CB
FG
HH
JI
OF
AJ
BK
GL
I - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-4-mer
- Ligands
- 20 x CA: CALCIUM ION(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x CFF: CAFFEINE(Non-covalent)
- 4 x KVR: 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)methyl]benzoic acid(Non-covalent)
- 8 x L9R: (2S)-3-(octadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Miotto, M.C., Targeting Ryanodine Receptors with Allopurinol and Xanthine Derivatives for the Treatment of Cardiac and Musculoskeletal Weakness Disorders. To Be Published
- Release Date
- 2024-10-30
- Peptides
- Calmodulin-1: ACDE
Peptidyl-prolyl cis-trans isomerase FKBP1A: BGHI
Ryanodine receptor 1: FJKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
KC
DD
EE
CB
FG
HH
JI
OF
AJ
BK
GL
I - Membrane
-
We predict this structure to be a membrane protein.